Scirica BM - Search Results

1

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes.

Moura FA, Berg DD, Bellavia A, Dwyer JP, Mosenzon O, Scirica BM, Wiviott SD, Bhatt DL, Raz I, Feinberg MW, Braunwald E, Morrow DA, Sabatine MS. Moura FA, et al. Among authors: scirica bm. Diabetes Care. 2023 Oct 1;46(10):1807-1815. doi: 10.2337/dc23-0492. Diabetes Care. 2023. PMID: 37556796 Free PMC article.

2

Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry.

Scirica BM, Cannon CP, Antman EM, Murphy SA, Morrow DA, Sabatine MS, McCabe CH, Gibson CM, Braunwald E. Scirica BM, et al. Am J Cardiol. 2002 Aug 1;90(3):303-5. doi: 10.1016/s0002-9149(02)02468-2. Am J Cardiol. 2002. PMID: 12127617 No abstract available.

3

Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification.

Scirica BM, Cannon CP, McCabe CH, Murphy SA, Anderson HV, Rogers WJ, Stone PH, Braunwald E; Thrombolysis in Myocardial Ischemia III Registry Investigators. Scirica BM, et al. Am J Cardiol. 2002 Oct 15;90(8):821-6. doi: 10.1016/s0002-9149(02)02701-7. Am J Cardiol. 2002. PMID: 12372567

4

Troponins in acute coronary syndromes.

Scirica BM, Morrow DA. Scirica BM, et al. Semin Vasc Med. 2003 Nov;3(4):363-74. doi: 10.1055/s-2004-815694. Semin Vasc Med. 2003. PMID: 15199443 Review.

5

Troponins in acute coronary syndromes.

Scirica BM, Morrow DA. Scirica BM, et al. Prog Cardiovasc Dis. 2004 Nov-Dec;47(3):177-88. doi: 10.1016/j.pcad.2004.07.004. Prog Cardiovasc Dis. 2004. PMID: 15736583 Review.

6

Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment.

Sabatine MS, Blake GJ, Drazner MH, Morrow DA, Scirica BM, Murphy SA, McCabe CH, Weintraub WS, Gibson CM, Cannon CP. Sabatine MS, et al. Among authors: scirica bm. Circulation. 2005 Mar 15;111(10):1217-24. doi: 10.1161/01.CIR.0000157733.50479.B9. Circulation. 2005. PMID: 15769761

7

Appropriate invasive and conservative treatment approaches for patients with non-ST-elevation MI.

Scirica BM, Morrow DA. Scirica BM, et al. Curr Treat Options Cardiovasc Med. 2006 Feb;8(1):13-21. doi: 10.1007/s11936-006-0022-x. Curr Treat Options Cardiovasc Med. 2006. PMID: 16401380

8

Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out.

Scirica BM, Morrow DA. Scirica BM, et al. Circulation. 2006 May 2;113(17):2128-34; discussion 2151. doi: 10.1161/CIRCULATIONAHA.105.611350. Circulation. 2006. PMID: 16651484 Review. No abstract available.

9

Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.

Scirica BM, Morrow DA, Cannon CP, Ray KK, Sabatine MS, Jarolim P, Shui A, McCabe CH, Braunwald E; PROVE IT-TIMI 22 Investigators. Scirica BM, et al. J Am Coll Cardiol. 2006 Jun 6;47(11):2326-31. doi: 10.1016/j.jacc.2006.03.034. Epub 2006 May 4. J Am Coll Cardiol. 2006. PMID: 16750703 Free article.

10

Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.

Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, Skene A, McCabe CH, Braunwald E; MERLIN-TIMI 36 Investigators. Morrow DA, et al. Among authors: scirica bm. Am Heart J. 2006 Jun;151(6):1186.e1-9. doi: 10.1016/j.ahj.2006.01.004. Am Heart J. 2006. PMID: 16781216 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters